The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.
All Keywords
【저자키워드】 Immunotherapy, HBV, Gene therapy, direct antiviral agents, therapeutic vaccines,
【저자키워드】 Immunotherapy, HBV, Gene therapy, direct antiviral agents, therapeutic vaccines,